Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of 'Post COVID Syndrome (AKA "Long Haul COVID Syndrome").
Tech Tuesday: Oneness Technologies
In this week's Tech Tuesday featured on WCJB TV20, we interview Dr. Neha Chavan and Alex Blanton from Oneness Technologies, a biotech company that combines cutting-edge scientific expertise with a plant-based medicine approach. The startup's technology revolutionizes the health and wellness industry by ensuring maximum absorption of hemp products in the body, minimizing wastage, and reducing side effects.
UF Startups Among Companies Selected for U.S. Funding to Reduce Carbon Emissions
UF startup Micro Nano Technologies, incubating at UF Innovate | Accelerate at The Hub, is one of six companies sharing $16.2 million in funding for decarbonizing paper and forest products. The goal is to reduce net energy GHG emissions in the paper and forest products industry including increasing the share of renewable energy used, electrification, carbon capture, and energy efficiency.
EU Adds 9 Startups to Contribute Data to Copernicus Mission
The European Union (EU) has added nine startups -- including Spain-based Satlantis, the parent company of UF startup Satlantis LLC -- to contribute data to the Copernicus project. Each startup will receive a 5 million euro contract to provide additional data to Copernicus.
Tech Tuesday: Fire Neural Network
In this week’s Tech Tuesday, we interview
Dr. Istvan Kereszy, CEO of Fire Neural Network (FNN), to explore their groundbreaking work in lighting detection and its crucial role in preventing wildfires. Hear how their advanced technological detectors can identify high-risk strikes and are helping mitigate fires.
Dmitry Rinberg on the Mysteries of Smell
"Don't miss this fascinating interview with Dmitry Rinberg, Co-founder and Chief Science Advisor of Canaery, a resident of UF Innovate | Accelerate, as he explores the mysteries of smell with Vasant Dhar. Join AI-pioneer Vasant Dhar as he hosts 'Brave New World' and discover the transformation of humanity by machines in the post-COVID era. The conversation will touch on various topics such as work, health, faith, emotional well-being, government, democracy, and freedom."
Slice Engineering Mosquito Prime Hotend Targets Speed and Reliability in 3D Printing
Florida-based Slice Engineering has launched the Mosquito Prime hotend, catering to the increasing demand for faster and more reliable 3D printing. The hotend offers improved thermal engineering and lightweight construction for high-flow extrusion and consistent high-quality prints.
Finding Fires With Lightning Speed
To address this urgent problem, Fire Neural Network (FNN), a company based in Gainesville, Florida, is utilizing artificial intelligence (AI) to expedite the identification of devastating wildfires from 24 hours to just 40 seconds.
You’re More Than the Phone in Your Hand: Entrepreneurial Hack of the Week
In a world where technology reigns supreme, concerns about AI's threat to jobs and the erosion of human relationships have reached a tipping point. But what if there's a genius hack to strike the perfect balance? In this thought-provoking article, Karl LaPan, Director of UF Innovate Accelerate, unravels the intricate relationship between technology, AI, and our fundamental need for genuine human connection.
MLM Biologics Developing Wound Infection Prevention Device for Military
MLM Biologics Inc., a graduate company of Sid Martin Biotech, has been awarded nearly $1.5 million by the US Army to develop a device that prevents infection in battlefield wounds. The device will utilize MLM Biologic's collagen processing and stabilization technologies. The focus is on preventing infection in complex, traumatic injuries in austere environments. The company plans to incorporate their proprietary technologies and proven anti-inflammatory and anti-microbial components, with potential civilian use in the future.
